12/13/2024
8:30 PM | LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
McCracken Joseph S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
8:30 PM | Lawley Lori D (Reporting)
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
8:30 PM | LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
POWERS BRADLEY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
8:31 PM | LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Schuchart Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
8:31 PM | LALANDE KEVIN M. (Reporting)
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
8:31 PM | LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Pitukcheewanont Pisit Duke (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
8:31 PM | LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Raffin Thomas A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
12/13/2024
8:31 PM | LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
van Es-Johansson An (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
8:32 PM | JOHNSON CHAD ALLEN (Reporting)
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
8:32 PM | LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
McKew John C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
8:32 PM | LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Zoth Lota S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
8:32 PM | Hawkins Richard J (Reporting)
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
7:10 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form AW | |
12/12/2024
11:15 PM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form EFFECT | |
12/12/2024
11:15 PM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form EFFECT | |
12/12/2024
11:15 PM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form EFFECT | |
12/12/2024
11:15 PM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form EFFECT | |
12/12/2024
11:15 PM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form EFFECT | |
12/12/2024
9:54 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form POS AM | |
12/12/2024
9:56 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form POS AM | |
12/12/2024
9:59 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form POS AM | |
12/12/2024
10:01 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form POS AM | |
12/12/2024
10:03 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form POS AM | |
12/12/2024
10:05 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form POS AM | |
12/12/2024
9:28 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
9:39 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form S-8 POS | |
12/12/2024
9:41 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form S-8 POS | |
12/12/2024
9:43 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form S-8 POS | |
12/12/2024
9:45 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form S-8 POS | |
12/12/2024
9:47 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form S-8 POS | |
12/12/2024
9:49 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form S-8 POS | |
12/12/2024
9:51 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form S-8 POS | |
12/12/2024
8:42 AM | LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
12/12/2024
8:42 AM | LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
| Form SC 14D9/A | |
12/12/2024
7:57 AM | Double Point Ventures LLC (Filed by)
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
| Form SC TO-T/A | |
11/29/2024
4:01 PM | Double Point Ventures LLC (Filed by)
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
| Form SC TO-T/A | |
11/29/2024
4:09 PM | LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
| Form SC 14D9/A | |
11/25/2024
5:02 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
8:04 AM | LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
| Form SC 14D9 | |
11/14/2024
7:22 AM | Double Point Ventures LLC (Filed by)
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
| Form SC TO-T | |
11/07/2024
2:12 PM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad) Elon Musk believes his new AI product will be worth an incredible $9 trillion.
But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. |
10/25/2024
9:43 AM | LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
WELLS FARGO & COMPANY/MN (Filed by)
| Form SCHEDULE 13G/A | |
10/23/2024
7:24 AM | LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
| Form SC14D9C | |
10/23/2024
7:10 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
4:09 PM | LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
McKew John C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
4:18 PM | LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
McKew John C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
4:19 PM | Lawley Lori D (Reporting)
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
7:18 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
4:07 PM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
6:45 PM | LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Pitukcheewanont Pisit Duke (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
8:57 AM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
3:30 PM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form 10-K/A | |
04/18/2024
3:53 PM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
3:32 PM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form ARS | |
04/12/2024
4:27 PM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form DEFA14A | |
04/12/2024
4:01 PM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form DEF 14A | |
03/20/2024
3:27 PM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
3:44 PM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
3:48 PM | LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/09/2024
6:14 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
| Form SC 13G/A | |
02/07/2024
4:22 PM | LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
McKew John C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
8:57 AM | LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
WELLS FARGO & COMPANY/MN (Filed by)
| Form SC 13G | |
02/05/2024
4:51 PM | LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
POWERS BRADLEY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
4:52 PM | LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Schuchart Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
4:53 PM | Lawley Lori D (Reporting)
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
6:03 PM | LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Pitukcheewanont Pisit Duke (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Free LUMO Stock Alerts